We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-3.25%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.01B
AUM Growth
+$262M
Cap. Flow
-$162M
Cap. Flow %
-2.7%
Top 10 Hldgs %
51.52%
Holding
592
New
224
Increased
125
Reduced
42
Closed
159

Top Buys

Rank Stock Value
1
WAY
Waystar Holding Corp
WAY
+$107M
2
GILD icon
Gilead Sciences
GILD
+$99.5M
3
CVS icon
CVS Health
CVS
+$61M
4
BAX icon
Baxter International
BAX
+$57.9M
5
CGEM icon
Cullinan Oncology
CGEM
+$45.6M

Top Sells

Rank Stock Value
1
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
+$136M
2
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$80.7M
3
SWTX
SpringWorks Therapeutics
SWTX
+$63.2M
4
OSCR icon
Oscar Health
OSCR
+$44.4M
5
VKTX icon
Viking Therapeutics
VKTX
+$38M

Sector Composition

Rank Sector Weight
1 Healthcare 83.29%
2 Industrials 0.69%
3 Technology 0.57%
4 Financials 0.44%
5 Consumer Discretionary 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LFMD icon
351
LifeMD
LFMD
$187M
$276K ﹤0.01%
40,289
+8,204
+26% +$75.1K
TARS icon
352
Tarsus Pharmaceuticals
TARS
$2.62B
$273K ﹤0.01%
+10,034
New +$337K
BHF icon
353
Brighthouse Financial
BHF
$3.63B
$270K ﹤0.01%
6,219
-1,301
-17% -$60K
DHC
354
Diversified Healthcare Trust
DHC
$2.28B
$269K ﹤0.01%
88,223
+4,055
+5% +$10.3K
FNB icon
355
FNB Corp
FNB
$6.71B
$266K ﹤0.01%
+19,421
New +$262K
AMPH icon
356
Amphastar Pharmaceuticals
AMPH
$846M
$265K ﹤0.01%
+6,623
New +$274K
REPL icon
357
Replimune Group
REPL
$724M
$264K ﹤0.01%
29,300
-773,684
-96% -$5.39M
VSTO
358
DELISTED
Vista Outdoor Inc.
VSTO
$262K ﹤0.01%
+6,967
New +$241K
DXC icon
359
DXC Technology
DXC
$1.68B
$260K ﹤0.01%
13,613
-48,632
-78% -$913K
CPRT icon
360
Copart
CPRT
$27.6B
$258K ﹤0.01%
+4,762
New +$260K
FIS icon
361
Fidelity National Information Services
FIS
$22.3B
$258K ﹤0.01%
+3,417
New +$253K
COOP
362
DELISTED
Mr. Cooper
COOP
$257K ﹤0.01%
+3,164
New +$254K
FRT icon
363
Federal Realty Investment Trust
FRT
$11B
$255K ﹤0.01%
+2,521
New +$254K
KMPR icon
364
Kemper
KMPR
$1.73B
$250K ﹤0.01%
+4,220
New +$248K
CIVI
365
DELISTED
Civitas Resources
CIVI
$250K ﹤0.01%
+3,625
New +$262K
PYPL icon
366
PayPal
PYPL
$49.5B
$250K ﹤0.01%
4,307
-1,908
-31% -$121K
UNH icon
367
UnitedHealth
UNH
$379B
$250K ﹤0.01%
490
– –
MTRN icon
368
Materion
MTRN
$5.03B
$247K ﹤0.01%
+2,287
New +$263K
HOOD icon
369
Robinhood
HOOD
$85.9B
$246K ﹤0.01%
+10,823
New +$212K
GOOGL icon
370
Alphabet (Google) Class A
GOOGL
$3.99T
$244K ﹤0.01%
1,340
-304
-18% -$51.2K
CVX icon
371
Chevron
CVX
$378B
$244K ﹤0.01%
+1,559
New +$249K
CI icon
372
Cigna
CI
$77B
$244K ﹤0.01%
+737
New +$254K
FWRD icon
373
Forward Air
FWRD
$466M
$242K ﹤0.01%
+12,703
New +$262K
BAC icon
374
Bank of America
BAC
$436B
$240K ﹤0.01%
+6,029
New +$231K
CYTK icon
375
Cytokinetics
CYTK
$10.9B
$237K ﹤0.01%
4,366
-1,398
-24% -$84.4K
13 14
15
16 17

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q2 2024 Portfolio in Review

As of Q2 2024, Deerfield Management held 592 positions worth $6.01B, up 4.6% from $5.75B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q2 2024 filing shows 224 new, 125 increased, 42 reduced and 159 closed positions. Its largest new stake was Waystar Holding Corp: 4,952,004 shares worth $106M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $136M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 89% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q2 2024 buy was Waystar Holding Corp: 4,952,004 shares worth $106M.
  • Deerfield Management added most to Baxter International in Q2 2024, an estimated $57.9M increase.
  • Deerfield Management's biggest Q2 2024 reduction was Oscar Health, cutting an estimated $44.4M.
  • Deerfield Management fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $136M.
  • Deerfield Management's ten largest holdings make up 52% of its $6.01B portfolio in Q2 2024.
  • Deerfield Management opened 224 new positions and closed 159 in Q2 2024.
  • Deerfield Management's portfolio value rose 4.6% quarter-over-quarter to $6.01B.

Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.